Overview
Details
Chat
BioNTech SE sponsored ADR SE (BNTX.US) Q1 2022 Earnings Conference Call.
Live streaming time: 09/05/2022 12:00
BioNTech SE Sponsored ADRSE is dedicated to the development of new drugs in the cross-field of immunology and synthetic biology. Its product line includes BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T cells, TCR, and next-generation CP immune modulators. The company was founded by Christopher Huber, Ozlem Tureci, and Ugur Sahin on June 2, 2008, and is headquartered in Mainz, Germany.
Risk and Disclaimer Statement:
The content on this page reflects the personal opinion of the author and is intended solely as general information for your reference. It shall not be construed as advice or a basis for any specific investment, business, or commercial decisions. The views expressed in the content do not represent any position of Longbridge or any investment recommendations or endorsements related to LongPort. Longbridge does not make any guarantee or commitment to the truthfulness, accuracy, or originality of the content. Investors should analyze the risks related to the investment based on their own circumstances and seek advice from a professional investment advisor when necessary.
© 2026 Longbridge|Disclaimer
